Icosagen In The News



Join RSS feed »
In the News

March 20, 2009

« Back to news list

The new business name of Quattromed Group is Icosagen Group

On 02 March 2009, the new business names of AS Quattromed and OÜ Quattromed Cell Factory were registered. The new business name of Quattromed AS is Icosagen AS, and the new business name of subsidiary Quattromed Cell Factory OÜ is Icosagen Cell Factory OÜ.

As of 01 November 2008, the activities of the Icosagen Group have been managed by Board Member of the Management Mart Ustav.


About the company

The Icosagen Group’s activity began in 1999, with the founding of medical molecular diagnostic company Quattromed AS. Two years later, the development of technologies and products based on molecular and cellular biology began. During the period 2001-2005, development work was directed towards the creation, development and sales of protein tagging and protein expression systems (E2Tag epitope tagging technology). In 2005, the company was restructured. On the basis of the medical diagnostics department, the subsidiary Quattromed Laborid OÜ was created (later Quattromed HTI Laborid OÜ). Subsidiary Quattromed Cell Factory OÜ was formed based on a science and development laboratory, and the technology development project for the elaboration of production technology (QMCF technology) for biological therapeutics was launched. Within the parent company there were significant improvements made to the existing antibody product portfolio, the natural rubber allergen detection technology FITkit® was acquired and a testing and reagent production laboratory for natural rubber allergens was also launched.

In October 2008, the medical diagnostic branch of the company, along with the Quattromed trade mark, was sold to new owners, who will continue with operating commercially in the field of medical diagnostics.

Currently, the Icosagen Group’s activities include the development, production and sale of biochemical, immunoassay, molecular and cellular biology products and services. The company’s activity is primarily directed towards external markets. There are three trade marks in the intellectual property portfolio, several patents and one international standard based on technology belonging to the Icosagen Group. There are also six patent application proceedings underway in various states in four patent families. The company’s management system meets the requirements of ISO 9001:2001 standards.

 

ADDITIONAL INFORMATION:

Mart Ustav
Member of the Management Board


ph: +372 737 7070